Restoration of sinus rhythm in patients with recent AF onset
Conditions
Brief summary
Percentage of patients with recent onset (<48 hours) AF who were restored to sinus rhythm within 3 hours of starting treatment with IV flecainide and PO ranolazine compared with IV flecainide monotherapy.
Detailed description
Time interval from initiation of treatment with IV flecainide and PO ranolazine versus IV flecainide monotherapy to restoration of sinus rhythm in patients with recent onset (<48 hours) AF, Percentage of patients with recent onset (<48 hours) AF who were restored to sinus rhythm within 6 hours of starting treatment with IV flecainide and PO ranolazine compared with IV flecainide monotherapy.
Interventions
DRUGRANOLAZINE
Sponsors
Win Medica Pharmaceutical A.E.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients with recent onset (<48 hours) AF who were restored to sinus rhythm within 3 hours of starting treatment with IV flecainide and PO ranolazine compared with IV flecainide monotherapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time interval from initiation of treatment with IV flecainide and PO ranolazine versus IV flecainide monotherapy to restoration of sinus rhythm in patients with recent onset (<48 hours) AF, Percentage of patients with recent onset (<48 hours) AF who were restored to sinus rhythm within 6 hours of starting treatment with IV flecainide and PO ranolazine compared with IV flecainide monotherapy. | — |
Countries
Greece
Outcome results
None listed